Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Multicenter Randomized Clinical Trial Comparing Gemcitabine Alone Or In Combination With Capecitabine For The Treatment Of Patients With Advanced Pancreatic Cancer

NCT00032175 is registered in ClinicalTrials.gov with Cancer Research UK as lead sponsor.

NCT NCT00032175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00032175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Multicenter Randomized Clinical Trial Comparing Gemcitabine Alone Or In Combination With Capecitabine For The Treatment Of Patients With Advanced Pancreatic Cancer
Lead sponsor
Cancer Research UK
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2002
Completion date
May 31, 2007
Enrollment
508 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer